Thermo Fisher reports Q2 2026 revenue up 10% to $12.0B, adjusted EPS rises 13% to $6.03

Filed July 23, 2026 · Period ending July 23, 2026 · ~1 min read

Key Changes

• high

  Q2 2026 revenue grew 10% year-over-year to $11.99 billion with 5% organic growth; adjusted EPS increased 13% to $6.03 (GAAP EPS up 9% to $4.68), driven by strengthening end markets and market share gains.

  Exhibit 99.1 view on EDGAR →
• high

  Adjusted operating margin expanded 90 basis points to 22.8% from 21.9% year-over-year, reflecting operational leverage and efficiency gains from the company's PPI Business System.

  Exhibit 99.1 view on EDGAR →
• high

  First half 2026 free cash flow surged 69% to $2.50 billion from $1.48 billion in the prior-year period, demonstrating strong cash generation capability.

  Exhibit 99.1 view on EDGAR →